OPG, high quality contract manufacturer for leading companies since 1995
Orofino Pharmaceuticals Group is a private company which was founded in 1993 as a provider of high quality contract manufacturing to the pharmaceutical industry.
Operations commenced in 1995 with the commissioning and construction of a purpose designed plant for the secondary manufacture of beta lactam antibiotics near Rome – Biopharma.
Following the success of this operation, The Group acquired a modern sterile manufacturing plant at another location also near Rome and undertook a major upgrading of facilities, equipment and technologies to establish a very modern, high technology plant for the manufacture of a wide range of sterile dosage forms – Injectalia.
Another plant near Naples was subsequently acquired and developed in order to be able to provide chemical testing and EU release of imported products and secondary packaging – K24 Pharmaceuticals.
In order to expand the range of pharmaceutical manufacturing services into APIs, a plant near Basel in Switzerland was acquired in 2009. This acquisition has broaden the scope of contract manufacturing services provided by The Group from secondary manufacture into primary manufacturing – Drug’on Pharma Switzerland.
Orofino Pharmaceuticals Group is focused on providing a wide range of cost competitive contract manufacturing services to the pharmaceutical industry with a major focus on high quality, high service and reliability as a strategic partner. It will continue to assess opportunities to expand the scope of its operations and increase the range of services available to its customers.